DK154841C - Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis - Google Patents

Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Info

Publication number
DK154841C
DK154841C DK475779A DK475779A DK154841C DK 154841 C DK154841 C DK 154841C DK 475779 A DK475779 A DK 475779A DK 475779 A DK475779 A DK 475779A DK 154841 C DK154841 C DK 154841C
Authority
DK
Denmark
Prior art keywords
membrane proteins
neisseria meningitidis
procedure
manufacturing membrane
optionally
Prior art date
Application number
DK475779A
Other languages
Danish (da)
English (en)
Other versions
DK475779A (da
DK154841B (da
Inventor
Torsten Bertil Helting
Gerhard Guthoehrlein
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK475779A publication Critical patent/DK475779A/da
Publication of DK154841B publication Critical patent/DK154841B/da
Application granted granted Critical
Publication of DK154841C publication Critical patent/DK154841C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK475779A 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis DK154841C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19782848965 DE2848965A1 (de) 1978-11-11 1978-11-11 Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
DE2848965 1978-11-11

Publications (3)

Publication Number Publication Date
DK475779A DK475779A (da) 1980-05-12
DK154841B DK154841B (da) 1988-12-27
DK154841C true DK154841C (da) 1989-06-05

Family

ID=6054405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK475779A DK154841C (da) 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Country Status (9)

Country Link
EP (1) EP0011243B1 (fr)
JP (1) JPS5566519A (fr)
AT (1) ATE857T1 (fr)
AU (1) AU533386B2 (fr)
CA (1) CA1142083A (fr)
DE (2) DE2848965A1 (fr)
DK (1) DK154841C (fr)
ES (1) ES485715A1 (fr)
IL (1) IL58673A (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH074267B1 (fr) * 1982-12-02 1995-01-25 Univ Rockefeller
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
US8007815B1 (en) 1998-05-29 2011-08-30 Novartis Ag Combination meningitidis B/C vaccines
DK2270173T3 (en) 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
CN1416352B (zh) 2000-01-17 2011-05-25 启龙股份公司 含有脑膜炎奈瑟球菌b血清群外膜蛋白质的外膜囊(omv)疫苗
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
WO2004015099A2 (fr) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Compositions de vaccins
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CU23313A1 (es) 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
JP5173194B2 (ja) * 2003-12-23 2013-03-27 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
JP5275983B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
CA2702871A1 (fr) 2007-10-19 2009-04-23 Novartis Ag Formulations de vaccin meningococcique
EP2245048B1 (fr) 2008-02-21 2014-12-31 Novartis AG Polypeptides fhbp à méningocoques
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
CN102300585A (zh) 2008-12-17 2011-12-28 诺华有限公司 包含血红蛋白受体的脑膜炎球菌疫苗
AU2010258677B2 (en) 2009-06-10 2016-10-06 Glaxosmithkline Biologicals S.A. Benzonaphthyridine-containing vaccines
AU2010288240B2 (en) 2009-08-27 2014-03-27 Novartis Ag Hybrid polypeptides including meningococcal fHBP sequences
CA2772103A1 (fr) 2009-08-27 2011-03-03 Novartis Ag Adjuvant contenant de l'aluminium, un oligonucleotide et une polycation
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
WO2011039631A2 (fr) 2009-09-30 2011-04-07 Novartis Ag Expression de polypeptides fhbp méningococciques
AU2010310985B2 (en) 2009-10-27 2014-11-06 Glaxosmithkline Biologicals S.A. Modified meningococcal fHBP polypeptides
WO2011057148A1 (fr) 2009-11-05 2011-05-12 Irm Llc Composés et compositions permettant de moduler l'activité des tlr-7
AU2010339921B2 (en) 2009-12-15 2016-08-11 Glaxosmithkline Biologicals S.A. Homogeneous suspension of immunopotentiating compounds and uses thereof
JP2013521770A (ja) 2010-03-10 2013-06-13 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン組成物
BR112012022896A2 (pt) 2010-03-18 2018-03-27 Novartis Ag vacinas adjuvantes para meningococos do sorogrupo b
EA031379B1 (ru) 2010-03-23 2018-12-28 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
CA2810971C (fr) 2010-09-10 2020-11-03 Novartis Ag Developpements apportes a des vesicules membranaires externes meningococciques
EP2707009A1 (fr) 2011-05-12 2014-03-19 Novartis AG Antipyrétiques pour améliorer la tolérabilité de vaccins à base de vésicules
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
EP2823312B1 (fr) 2012-03-08 2019-08-07 GlaxoSmithKline Biologicals SA In vitro essai d'activite des vaccins a base de proteines méningococciques
WO2013186753A1 (fr) 2012-06-14 2013-12-19 Novartis Ag Vaccins contre le méningocoque de sérogroupe x
JP6324961B2 (ja) 2012-09-06 2018-05-16 ノバルティス アーゲー 血清群ｂ髄膜炎菌とｄ／ｔ／ｐとの組み合わせワクチン
AU2013320313B2 (en) 2012-09-18 2018-07-12 Glaxosmithkline Biologicals Sa Outer membrane vesicles
CA2940447C (fr) 2014-02-28 2023-07-11 Glaxosmithkline Biologicals Sa Polypeptides fhbp meningococciques modifies
US12109259B2 (en) 2016-09-02 2024-10-08 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
KR20200053531A (ko) 2017-09-08 2020-05-18 에벨로 바이오사이언시즈, 인크. 박테리아 세포외 소포
EP3607967A1 (fr) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Polypeptides modifiés du méningocoque fhbp
CN112996538A (zh) 2018-11-06 2021-06-18 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
EP3799884A1 (fr) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Compositions immunogènes
GB202115072D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202211033D0 (en) 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process

Also Published As

Publication number Publication date
JPS6350332B2 (fr) 1988-10-07
ES485715A1 (es) 1980-05-16
CA1142083A (fr) 1983-03-01
DK475779A (da) 1980-05-12
IL58673A0 (en) 1980-02-29
ATE857T1 (de) 1982-04-15
DE2848965A1 (de) 1980-05-22
DE2962526D1 (en) 1982-05-27
AU5268279A (en) 1980-05-15
AU533386B2 (en) 1983-11-24
IL58673A (en) 1983-02-23
DK154841B (da) 1988-12-27
EP0011243A1 (fr) 1980-05-28
EP0011243B1 (fr) 1982-04-14
JPS5566519A (en) 1980-05-20

Similar Documents

Publication Publication Date Title
DK154841C (da) Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis
DE69423383D1 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
DE69116305D1 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
ATE123947T1 (de) Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
MX165343B (es) Tratamiento de membranas permeables
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
DK565986D0 (da) Fremgangsmaade og apparat til forbedring af ristet kaffe
EP0607593A3 (fr) Procédé d'obtention de cultures cellulaires avec un taux amélioré de cytonines autogènes.
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
DE3265664D1 (en) Process for the production of a biochemical vaccine against salmonella fevers
ATE118008T1 (de) Verfahren zur herstellung von aminomethanphosphonsäure und aminomethyl- phosphinsäuren.
FR2620726B1 (fr) Procede de preparation d'un extrait de jasmin et extrait obtenu
DK0470086T3 (da) Fremgangsmåde til rensning af hæmin, et nyt hæmin-derivat samt en fremgangsmåde til dets fremstilling
ATE101393T1 (de) Phenanthridinderivate, verfahren zu ihrer herstellung und mittel zur ausfuehrung des verfahrens.
SU1564190A1 (ru) Способ получени препарата фотосинтетических реакционных центров, содержащих фотоактивные цитохромы
DK222887A (da) Fremgangsmaade til fremstilling af l-aminosyrer ved fermentering af alfa-ketocarboxylsyrer
ATE1239T1 (de) Verfahren zur herstellung von 4-amino-5-chlor-1-phenyl-pyridazon-(6).
GB1556005A (en) Process for ozone treatment of water
DK632187D0 (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
JPS6410950A (en) Elimination of taste and odor of substance rich in amino acid
DE69709750D1 (de) Verfahren zur herstellung von 4,4,4-trichlorbutanol
UA14449A1 (uk) Спосіб отримаhhя паhтокриhа для іh'єкцій
KR850003668A (ko) 피혁 폐기물의 가축사료 제조방법

Legal Events

Date Code Title Description
PBP Patent lapsed